Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Researchers used CRISPR to change the number of chromosomes in Arabidopsis by fusing chromosome arms, reducing the genome ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
Researchers developed Bits2Bonds, a platform that merges molecular dynamics simulations with machine learning to design new ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...